Pasithea Therapeutics : Shareholder Meeting - Form 8-K

Item 5.08 Shareholder Director Nominations

On May 13, 2024, Pasithea Therapeutics Corp. (the "Company") scheduled its 2024 annual meeting of stockholders (the "2024 Annual Meeting") to be held via the Internet, on June 26, 2024, at 9:00 a.m., Eastern time and established April 29, 2024, as the record date for determining stockholders entitled to notice of, and to vote at, the 2024 Annual Meeting.

Since the date of the 2024 Annual Meeting will be more than 30 days from the anniversary of the Company's 2023 annual meeting of stockholders, the deadline for submission of proposals by stockholders for inclusion in the Company's proxy materials in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Company's Second Amended and Restated Bylaws (the "Bylaws"), will be the close of business on May 24, 2024.

Proposals by stockholders must meet the requirements set forth in the rules and regulations of the Exchange Act and the Company's Bylaws in order to be eligible for inclusion in the proxy materials for the 2024 Annual Meeting. Any such proposal shall be mailed to the Company at:1111 Lincoln Road, Suite 500, Miami Beach, FL 33139.